Review Finds Antihistamines Provide Minimal Relief for Eczema Patients

A recent review published in the BMJ raises questions about the effectiveness of antihistamines in managing eczema symptoms. The analysis, which included 47 clinical trials involving over 6,200 children and adults with atopic dermatitis, found that these drugs provide only minor improvements in itching and skin inflammation.

Eczema, or atopic dermatitis, is a chronic skin condition characterized by dry, itchy, and inflamed skin, affecting millions worldwide. Despite widespread use of antihistamines to alleviate itching and aid sleep during flare-ups, the review suggests the benefits are generally too small for patients to notice.

Key Findings

• Antihistamines reduced eczema severity by just 1.87 points on an 83-point scale.
• Improvement in itching was less than one point on a 10-point scale, below clinically meaningful thresholds.
• The drugs did not significantly reduce the frequency of eczema flare-ups.
• Older antihistamines, known to cause drowsiness, were linked to increased risks of cognitive issues such as confusion and memory problems.

The researchers emphasize that eczema-related itching is not solely caused by histamine but is linked to skin inflammation and barrier damage. Consequently, antihistamines may not target the underlying causes effectively.

Implications for Treatment

While antihistamines may still be useful for other allergic conditions like hay fever or hives, their routine use for eczema is questionable. Experts recommend that patients with persistent or severe eczema consult healthcare professionals to explore treatments that focus on reducing inflammation and repairing the skin barrier.

Standard eczema management includes regular moisturising to maintain skin hydration and topical anti-inflammatory medications to control redness and swelling. The World Health Organization advises proper skin care and treatment of infections to prevent complications from poorly controlled eczema.

Overall, the review highlights the need for caution when using antihistamines for eczema due to their limited benefit and potential side effects, especially with older sedating variants.